NAGIOS: RODERIC FUNCIONANDO

A Systematic review to identify the effects of biologics in the feet of patients with rheumatoid arthritis

Repositori DSpace/Manakin

IMPORTANT: Aquest repositori està en una versió antiga des del 3/12/2023. La nova instal.lació está en https://roderic.uv.es/

A Systematic review to identify the effects of biologics in the feet of patients with rheumatoid arthritis

dc.contributor.author	Ramos-Petersen, Laura
dc.contributor.author	Nester, Christopher James
dc.contributor.author	Reinoso-Cobo, Andres
dc.contributor.author	Nieto Gil, Maria Pilar
dc.contributor.author	Ortega Avila, Ana Belén
dc.contributor.author	Gijon Nogueron, Gabriel
dc.date.accessioned	2021-04-13T08:17:32Z
dc.date.available	2021-04-13T08:17:32Z
dc.date.issued	2020
dc.identifier.citation	Ramos-Petersen, Laura Nester, Christopher James Reinoso-Cobo, Andres Nieto Gil, Maria Pilar Ortega Avila, Ana Belén Gijon Nogueron, Gabriel 2020 A Systematic review to identify the effects of biologics in the feet of patients with rheumatoid arthritis Medicina (Kaunas)
dc.identifier.uri	https://hdl.handle.net/10550/78584
dc.description.abstract	Background and objective: Ninety percent of patients with rheumatoid arthritis (RA) feel foot pain during the disease process. Pharmacological treatment of RA has a systematic effect on the body and includes: Nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs (DMARDs) and biologics. The objective of our review was to examine the impact of biologics on patients with RA 'foot. Methods and material: A systematic review of randomized control trials and observational studies that evaluated the efficacy of biologics against other pharmacological treatment, and included a foot outcome measure. The search covered MEDLINE Ovid, Pubmed, CINAHL, Cochrane Library, Evidence Search, and Web of Science. Risk of bias was evaluated using Cochrane guidance and the Newcastle Ottawa Scale adapted version. Results: A total of eight studies fully met the inclusion criteria: Three randomized control trials, and five observational studies were the basis of our review. A total sample of 1856 RA patients with RA treatment participated. The use of biologics was not associated as a risk factor for post-operative surgical site infection or delayed wound healing. The benefits of biologics, in terms of the disease evolution, were assessed using Xray. Conclusion: Evidence suggests that the use of biologics is not a risk factor for post-operative surgical site infection or delayed wound healing. The use of biologics presents benefits in terms of the disease evolution assessed through X-ray.
dc.language.iso	eng
dc.relation.ispartof	Medicina (Kaunas), 2020
dc.subject	Artritis
dc.title	A Systematic review to identify the effects of biologics in the feet of patients with rheumatoid arthritis
dc.type	journal article	es_ES
dc.date.updated	2021-04-13T08:17:33Z
dc.identifier.doi	10.3390/medicina57010023
dc.identifier.idgrec	144595
dc.rights.accessRights	open access	es_ES